Literature DB >> 18465769

Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.

David S Riddle1, Peter J Miller, Benjamin G Vincent, Thomas B Kepler, Rob Maile, Jeffrey A Frelinger, Edward J Collins.   

Abstract

CD8 plays an important role in the activity of cytolytic T cells (CTL). However, whether or not CD8 is required for the development of CTL has not been clearly determined. Cytotoxic activity in the CD8alpha knockout mouse is difficult to induce, and has only been demonstrated against allogenic MHC targets. The lack of cytotoxicity may result from impaired lineage commitment of CTL in the absence of CD8, or diminished competitiveness during selection against (unimpaired) development of CD4(+) T cells on MHC class II (MHC II). To differentiate between these possibilities, we have generated a double-knockout mouse (MHC II(-/-)CD8alpha(-/-)). In MHC II(-/-)CD8alpha(-/-) mice, developing MHC class I (MHC I)-reactive thymocytes cannot rely upon CD8 for selection, but they also cannot be overwhelmed by efficient selection of MHC II-reactive thymocytes. In this mouse, a large, heterogeneous population of peripheral coreceptor double-negative (DN) and CD4(+) T cells develops. Peripheral DN T cells are fully functional CTL. They display cytolytic activity against allogeneic MHC, and against syngeneic MHC following lymphocytic choriomeningitis virus (LCMV) infection. Cells from LCMV-infected mice bind more MHC I tetramer at lower concentrations than their wild-type CTL counterparts. These results demonstrate unequivocally that CD8 is not required for commitment of thymocytes to the CTL lineage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465769      PMCID: PMC2957804          DOI: 10.1002/eji.200737710

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  39 in total

Review 1.  T-cell development and the CD4-CD8 lineage decision.

Authors:  Ronald N Germain
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

Review 2.  CD4/CD8 lineage commitment: light at the end of the tunnel?

Authors:  Xiao He; Dietmar J Kappes
Journal:  Curr Opin Immunol       Date:  2006-02-15       Impact factor: 7.486

3.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

4.  CD8 is needed for development of cytotoxic T cells but not helper T cells.

Authors:  W P Fung-Leung; M W Schilham; A Rahemtulla; T M Kündig; M Vollenweider; J Potter; W van Ewijk; T W Mak
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

5.  Mice lacking all conventional MHC class II genes.

Authors:  L Madsen; N Labrecque; J Engberg; A Dierich; A Svejgaard; C Benoist; D Mathis; L Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

6.  A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection.

Authors:  Jennifer Buslepp; Huanchen Wang; William E Biddison; Ettore Appella; Edward J Collins
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

7.  Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins.

Authors:  A M Shenoy-Scaria; L K Gauen; J Kwong; A S Shaw; D M Lublin
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

8.  Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice.

Authors:  Felix J Baker; Mark Lee; Yueh-hsiu Chien; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

9.  CD8 lineage commitment in the absence of CD8.

Authors:  A W Goldrath; K A Hogquist; M J Bevan
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

10.  CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.

Authors:  M Mieno; R Suto; Y Obata; H Udono; T Takahashi; H Shiku; E Nakayama
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

View more
  4 in total

1.  IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells.

Authors:  Osamu Imataki; Sascha Ansén; Makito Tanaka; Marcus O Butler; Alla Berezovskaya; Matthew I Milstein; Kiyotaka Kuzushima; Lee M Nadler; Naoto Hirano
Journal:  J Immunol       Date:  2012-01-11       Impact factor: 5.422

2.  Phenotypic and functional evaluation of CD3+CD4-CD8- T cells in human CD8 immunodeficiency.

Authors:  Iván Bernardo; Esther Mancebo; Ignacio Aguiló; Alberto Anel; Luis M Allende; Juan M Guerra-Vales; Jesús Ruiz-Contreras; Antonio Serrano; Paloma Talayero; Oscar de la Calle; Cecilia Gonzalez-Santesteban; Estela Paz-Artal
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

3.  Duality of the murine CD8 compartment.

Authors:  Raphaël Genolet; Julie Leignadier; Magne Østerås; Laurent Farinelli; Brian J Stevenson; Immanuel F Luescher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-04       Impact factor: 11.205

4.  Specifically differentiated T cell subset promotes tumor immunity over fatal immunity.

Authors:  Abdulraouf Ramadan; Brad Griesenauer; Djamilatou Adom; Reuben Kapur; Helmut Hanenberg; Chen Liu; Mark H Kaplan; Sophie Paczesny
Journal:  J Exp Med       Date:  2017-10-16       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.